A new national analysis finds that telemedicine now delivers nearly 20% of PrEP in the United States. In 2024, more than 110,000 of about 580,000 PrEP users received medication through telemedicine. This share rose from under 1% in 2019 and from 9% in 2022.
Researchers combined national PrEP prescription counts with de-identified data from a large telePrEP provider. Total PrEP use also grew, from about 264,000 users in 2019 to more than 591,000 in 2024. The study highlights telehealth as a way to reduce barriers and help people stay in care.
Difficult words
- telemedicine — medical care by phone or video
- telehealth — health services using technology and internet
- prescription — a doctor's written order for medicine
- provider — an organization or person giving health care
- de-identified — personal data with names and identifiers removed
- barrier — something that makes access difficultbarriers
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever used telemedicine to see a health worker? What was it like?
- Do you think telehealth can help people stay in care? Why or why not?
- What problems might stop someone from using telemedicine or telehealth?
Related articles
Study: Industrial Revolution pollution affected people unevenly in England
A study in Science Advances used bones and historical records to track pollution exposure during the Industrial Revolution. Researchers analysed remains from 94 people in industrial South Shields and rural Barton-upon-Humber and found uneven, gendered exposure.
Cherry compounds may slow triple-negative breast cancer
Researchers at Texas A&M report that anthocyanins from dark sweet cherries slowed tumour growth and reduced metastasis in mice, and that combining them with chemotherapy helped control tumours. Further research is needed on safety and absorption.
Rwanda strengthens response to Rift Valley Fever outbreak
Rwanda reported a second Rift Valley Fever outbreak near the Tanzania border and has increased surveillance and livestock vaccination. Officials say lack of rapid diagnostic tests slows detection, while a human vaccine candidate enters Phase II trials.